BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Application for BTK Inhibitor BRUKINSA™ (zanubrutinib) in Israel

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice